Researchers Submit Patent Application, "Pharmaceutical Compositions And Combinations Comprising Inhibitors Of The Androgen Receptor And Uses Thereof", for Approval (USPTO 20240261282).

The article reports on a patent application for pharmaceutical composition and combinations comprising inhibitors of the androgen receptors and uses thereof by the inventors Peter Virsik and Han-Jie Zhou, filed on March 5, 2024 and was made available online on August 8, 2024. Topics include quote from the background information supplied by the inventors, evidence that show that androgens are associated with the development of prostate carcinogenesis, and summary information on the patent.